Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Exclusion Criteria

• •Have primary brain tumor, known metastases to the brain, central nervous system (CNS) lymphoma;
• •Have any major, focal structural loss of brain matter;
• •Are aggressively being treated with life sustaining measures (e.g. currently on respirator; receiving high dose chemotherapy);
• •Have a clinically significant infectious disease, including Acquired Immune Deficiency Syndrome (AIDS), Human Immunodeficiency Virus (HIV) infection, previous positive test for hepatitis or HIV or Creutzfeldt-Jakob disease (CJD);
• •Are receiving any investigational medications, or have participated in a trial with investigational medications within the last 30 days;
• •Have ever participated in an experimental study with an amyloid targeting agent (e.g. anti-amyloid immunotherapy, secretase inhibitor);
• •Have had a radiopharmaceutical imaging or treatment procedure within 7 days prior to the study imaging session; or
• •Are females of childbearing potential who are pregnant or not using adequate contraception.